Fractyl Health (GUTS) Other financing activities (2023 - 2026)
Fractyl Health's (GUTS) quarterly Other financing activities came in at $4.1 million in Q1 2026, up 1349.29% YoY from $280000.0 in Q1 2025, and down 79.44% on a QoQ basis from $19.7 million in Q4 2025.
Fractyl Health (GUTS) Other financing activities (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Other financing activities data on file, last reported at $4.1 million in Q1 2026.
- Quarterly Other financing activities rose 1349.29% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.5 million (down 77.35% YoY) and the FY2025 annual result came in at $19.7 million, down 80.97% from the prior year.
- Other financing activities eased to $4.1 million in Q1 2026, from $19.7 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $103.5 million in Q2 2024 to a low of -$280000.0 in Q3 2025.
- A 4-year average of $15.9 million and a median of $221500.0 in 2024 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2025 — Other financing activities jumped 71.78% — and 2026, when it soared 1349.29%.
- Tracing GUTS's Other financing activities over 4 years: stood at $17000.0 in 2023, then surged by 608911.76% to $103.5 million in 2024, then tumbled by 80.94% to $19.7 million in 2025, then slumped by 79.44% to $4.1 million in 2026.
- The last three Other financing activities figures came in at $4.1 million (Q1 2026), $19.7 million (Q4 2025), and -$280000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Fractyl Health | 123.81 Mn | 123.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.06 Mn |
| Mar 31, 2026 | 4.06 Mn |
| Dec 31, 2025 | 19.74 Mn |
| Dec 31, 2025 | 19.74 Mn |
| Sep 30, 2025 | -280,000.00 |
| Sep 30, 2025 | -280,000.00 |
| Mar 31, 2025 | 280,000.00 |
| Mar 31, 2025 | 280,000.00 |
| Jun 30, 2024 | 103.53 Mn |
| Jun 30, 2024 | 103.53 Mn |
| Mar 31, 2024 | 163,000.00 |
| Mar 31, 2024 | 163,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |